Virologist Chepurnov stated that there is no information about the effectiveness of the EpiVac vaccine the vaccine of the “Vector” center “EpiVac” has at least some effectiveness, including for children, said virologist Alexander Chepurnov. In a conversation with Lenta.ru, he added that for the vaccination of persons under the age of 18, KoviVac would be better suited, which does not give very high results for the adult population, but is able to show good efficiency in children, more sensitive, immune system.
The Vector center said that the EpiVacCorona and EpiVacCorona-N vaccines could potentially be used to vaccinate children. But, according to Chepurnov, the question here is not whether it is possible to use the drug for this group of people, but why the state has not yet closed such an ineffective project.
that this vaccine has at least some effectiveness. You can get any vaccine you want, but people will still remain unprotected. I think this shop should just be covered up, ”the virologist believes.
The fact that the vaccine does not work in an adult organism, but can work in a child, Chepurnov excludes: according to him, there are no theoretical prerequisites for the drug to work at least somehow.
“We know that there is not a single immunological manifestation in terms of humoral or cellular immunity that would allow us to hope for something. If there were even minor manifestations, it might make sense, since the children's immune system is very sensitive. So, for example, “KoviVac” can be very convenient. I don't see any significant antibody build-up after this vaccine, but it's pretty good for those who have been ill. It could be the same with children. What is a childhood vaccine? Basically, it's just a reduced adult dosage. But I do not see any signs of immunogenicity in EpiVac, so there is no reason to believe that it can be effective for the child contingent, “Chepurnov concluded.
Over the past day, 39,400 new cases of coronavirus were detected in Russia … Thus, the total number of infections in the country since the beginning of the pandemic was 8,834,495.